|
REXO2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.45579992505418E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.37019999971677E-07 |
| Normal-vs-Stage2 |
1.527900E-02 |
| Normal-vs-Stage3 |
2.65699999779656E-08 |
| Normal-vs-Stage4 |
3.168300E-04 |
| Stage1-vs-Stage2 |
9.364800E-01 |
| Stage1-vs-Stage3 |
4.837500E-02 |
| Stage1-vs-Stage4 |
4.099800E-01 |
| Stage2-vs-Stage3 |
2.494000E-01 |
| Stage2-vs-Stage4 |
6.462800E-01 |
| Stage3-vs-Stage4 |
4.735200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76380038247248E-10 |
| Normal-vs-AfricanAmerican |
5.900300E-03 |
| Normal-vs-Asian |
1.15610000017696E-07 |
| Caucasian-vs-AfricanAmerican |
7.094800E-01 |
| Caucasian-vs-Asian |
1.367970E-01 |
| AfricanAmerican-vs-Asian |
1.066580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.28386231937839E-14 |
| Normal-vs-Female |
2.136200E-02 |
| Male-vs-Female |
2.18639999999271E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.142400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.82420000111239E-08 |
| Normal-vs-Age(61-80Yrs) |
1.79229999730524E-08 |
| Normal-vs-Age(81-100Yrs) |
2.706400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.734200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.763000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.058000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.486200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.684400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.218400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.649800E-01 |
| Normal-vs-Grade 2 |
2.31430000052768E-07 |
| Normal-vs-Grade 3 |
1.36399999994818E-06 |
| Normal-vs-Grade 4 |
3.455899999949E-06 |
| Grade 1-vs-Grade 2 |
2.928400E-01 |
| Grade 1-vs-Grade 3 |
1.060360E-01 |
| Grade 1-vs-Grade 4 |
2.782100E-02 |
| Grade 2-vs-Grade 3 |
5.421400E-01 |
| Grade 2-vs-Grade 4 |
9.921500E-02 |
| Grade 3-vs-Grade 4 |
2.896200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.162300E-02 |
| Normal-vs-ccB subtype |
1.7439383270812E-12 |
| ccA subtype-vs-ccB subtype |
2.35390000002944E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64490000509332E-08 |
| Normal-vs-N1 |
1.073620E-02 |
| N0-vs-N1 |
2.715400E-01 |
|
|
